Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3693]

Proton pump inhibitors may affect responses to atezolizumab in patients with urothelial cancer

Proton pump inhibitors may affect responses to atezolizumab in patients with urothelial cancer

Attacking tumours directly on identification

Attacking tumours directly on identification

Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies

Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies

Effective cancer immunotherapy further linked to regulating a cell 'suicide' gene

Effective cancer immunotherapy further linked to regulating a cell 'suicide' gene

Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in low-grade gliomas

Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone...

New hydrogels for T-cell growth to be used in cancer immunotherapy

New hydrogels for T-cell growth to be used in cancer immunotherapy

Researchers identify mechanism underlying cancer cells' immune evasion

Researchers identify mechanism underlying cancer cells' immune evasion

New tool identifies which cancer patients are most likely to benefit from immunotherapy

New tool identifies which cancer patients are most likely to benefit from immunotherapy

New therapy targets breast cancer metastases in brain

New therapy targets breast cancer metastases in brain

Adapting ideas from quantum physics to calculate alternative interventions for infection and cancer

Adapting ideas from quantum physics to calculate alternative interventions for infection and cancer

More from ecancer